Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 807 results for "Fda Good Manufacturing Practices"

Wockhardt tanks over 10% on import alert from US FDA for Ankleshwar plant
Business Standard India

Wockhardt slumps 10%

The US Food and Drugs Administration (FDA) issued an import alert on Ankleshwar plant for alleged violation of good manufacturing practices, says report. India Infoline, 3 weeks ago
USFDA ISSUES IMPORT ALERT TO WOCKHARDT Pharmacy Choice, 3 weeks ago
WOCKHARDT : slumps 10% 4 Traders, 3 weeks ago
[x]  

48 images for Fda Good Manufacturing Practices

Livemint.com, 3 weeks ago
IChainnel, 1 week ago
American Pharmaceutical Review, 11 hours ago
Federal Register, 4 days ago
Pharmaceutical Tech.com, 2 days ago
Federal Register, 4 days ago
Federal Register, 4 days ago
Federal Register, 4 days ago
Money Control, 3 days ago
MSN Canada, 1 month ago

BRIEF-Alexion Pharmaceuticals-FDA recently completed routine current good manufacturing practice inspection of Cos Smithfield, Rhode Island Manufacturing Facility

Aug 8 Alexion Pharmaceuticals Inc * Fda recently completed routine current good manufacturing practice inspection of Co's Smithfield, Rhode island manufacturing facility * FDA observations also pertain to monitoring of water systems * ...
 Reuters UK2 weeks ago US FDA raises concerns about Alexion's Rhode Island Soliris facility  BioPharma-Reporter.com2 weeks ago FDA Concerned Over Quality Issues at Alexion's Soliris Facility  BioSpace2 weeks ago

Valeant Pharma Receives FDA Letter Related To CGMP At Bausch + Lomb Facility

The company said the concerns raised by the FDA pertain to a Current Good Manufacturing Practice inspection at Bausch + Lomb's manufacturing facility in Tampa, Florida where some deficiencies were identified. For comments and feedback:
 Nasdaq1 month ago
[x]  

Lapses push Pfizer to shut Chennai unit temporarily

MUMBAI: Pfizer is the latest addition to an expanding list of drug makers found deviating from good manufacturing practices in India. In the last week of June, a high profile team drawn from world's four leading regulators identified a number of ...
 Economic Times3 weeks ago Pfizer adds to list of drugmakers under lens for deviating from good manufacturing practices  Economic Times3 weeks ago
Fortune

FDA raises concerns over manufacturing practice of Valeant's new ophthalmic solution

The US Food and Drug Administration has raised concerns over manufacturing practice of Valeant Pharmaceuticals International's new eye drop. Valeant has received a complete response letter (CRL) from the FDA for latanoprostene bunod (LBN) ...
 Pharmaceutical Business Review1 month ago FDA raises concerns about manufacturing facility in latanoprostene bunod complete response letter to Valeant  Healio1 month ago The FDA Sees a Problem with Valeant's New Glaucoma Eye Drops  Fortune1 month ago FDA raises manufacturing concerns in complete response letter for Valeant's Vesneo eye drop  FirstWord Pharma1 month ago
[x]  

Natural Products Association launches warning letter database

Dietary supplement manufacturers, distributors and retailers can monitor and track the top good manufacturing practices violations by year and see how those trends are changing. The database will also allow end users to create their own reports. ...
 New Hope 3601 month ago NPA Launches Warning Letter Database for Member Companies  Asia Food Journal3 weeks ago

Manufacturing issues thwart FDA approval for Valeant eye drug

It had been a good week Valeant ($VRX) after an FDA panel backed its skin drug brodalumab and then the regulator gave the thumbs up for an oral version of its constipation drug Relistor--but its good fortune has come to an end as the FDA has today ...
 FierceBiotech1 month ago Fresh off Relistor win, Valeant hits FDA roadblock for eye drug  BioPharma Dive1 month ago
Pharmafile

ADMA CRL Isolated to Partner Manufacturing Issues: Anticipate 8 Month Delay

By John Vandermosten, CFA NASDAQ:ADMA FDA Issues Complete Response Letter Regarding RI-002 The Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to ADMA Biologics, Inc. ( ADMA ) regarding its Biologics License ...
 Yahoo! Finance3 weeks ago Valeant Pharmaceuticals Receives Complete Response Letter from FDA  CPhI.cn1 month ago Valeant's New Glaucoma Drug Raises No Safety or Efficacy Concerns With FDA  Vision Monday1 month ago Valeant Pharma gets US FDA Complete Response Letter for latanoprostene bunod ophthalmic solution NDA  PharmaBiz1 month ago
[x]  

FDA paves a path for OTC naloxone

In a blog posted by Karen Mahoney, MD, a deputy director for FDA, the agency vowed that it would assist pharmaceutical manufacturers in submitting applications for approval of over-the-counter (OTC) naloxone. The drug is still classified as a ...
 Behavioral Healthcare Magazine2 weeks ago

TruTag Technologies Manufacturing Plant Achieves GMP Compliancecompliance

TruTag Technologies silica microtag manufacturing facility in Kapolei, Hawaii has achieved compliance with current Good Manufacturing Practices (cGMP) for the manufacturing of TruTag microtags (TruTags) to protect pharmaceutical and food products ...
 CPhI.cn2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Fda Good Manufacturing Practices
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less